Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

CompletedOBSERVATIONAL
Enrollment

1,507

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

Dimethyl fumarate

Administered as specified in the treatment arm.

Trial Locations (32)

Unknown

Research Site, Amiens

Research Site, Besançon

Research Site, Bordeaux

Research Site, Brest

Research Site, Caen

Research Site, Clermont-Ferrand

Research Site, Dijon

Research Site, Grenoble

Research Site, Île-de-France - Bicêtre

Research Site, Île-de-France - Créteil

Research Site, Île-de-France - Poissy St-Germain

Research Site, Île-de-France - Pontoise

Research Site, Île-de-France - Rothschild

Research Site, Île-de-France - Saint-Antoine

Research Site, Île-de-France - Saint-Denis

Research Site, Île-de-France - Salpêtrière

Research Site, Lille

Research Site, Limoges

Research Site, Lyon

Research Site, Marseille

Research Site, Montpellier

Research Site, Nancy

Research Site, Nantes

Research Site, Nice

Research Site, Nîmes

Research Site, Poitiers

Research Site, Rennes

Research Site, Rouen

Research Site, Saint-Etienne

Research Site, Strasbourg

Research Site, Toulouse

Research Site, Tours

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY